Work

Responses to subsequent anti-HER2 therapy after treatment with trastuzumab-DM1 in women with HER2-positive metastatic breast cancer

Year: 2011

Type: article

Study design: Observational Study

Source: Annals of Oncology

DOI: 10.1093/annonc/mdr061

Authors: E.M. Olson, N.U. Lin, P.J. DiPiro, J.S. Najita, I.E. Krop, E.P. Winer, H.J. Burstein

Institutions: Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Public Health Service, National Cancer Institute

Awards: G5177619731, Cancer and Leukemia Group B, G973482110

OpenAlex ID: W2164078400

FWCI: 2.83

Cites: 13

Cited by: 29

Related to: 10